IL156303A0 - Method of collecting placental stem cells - Google Patents

Method of collecting placental stem cells

Info

Publication number: IL156303A0
Authority: IL; Israel
Prior art keywords: stem cells; placental stem; collecting placental; collecting; cells
Prior art date: 2000-12-06

Application number

IL15630301A

Other languages

English (en)

Original Assignee

Robert J Hariri

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-06

Filing date

2001-12-05

Publication date

2004-01-04

2001-12-05 Application filed by Robert J Hariri filed Critical Robert J Hariri

2004-01-04 Publication of IL156303A0 publication Critical patent/IL156303A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
- C12M29/10—Perfusion
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0462—Placental blood, umbilical cord blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/14—Female reproductive, genital organs
- A61M2210/1433—Uterus
- A61M2210/1458—Placenta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/14—Female reproductive, genital organs
- A61M2210/1433—Uterus
- A61M2210/1466—Umbilical cord
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Developmental Biology & Embryology (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Pregnancy & Childbirth (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Sustainable Development (AREA)
Immunology (AREA)
Anesthesiology (AREA)

IL15630301A 2000-12-06 2001-12-05 Method of collecting placental stem cells IL156303A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25190000P	2000-12-06	2000-12-06
PCT/US2001/046506 WO2002046373A1 (en)	2000-12-06	2001-12-05	Method of collecting placental stem cells

Publications (1)

Publication Number	Publication Date
IL156303A0 true IL156303A0 (en)	2004-01-04

Family

ID=22953866

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
IL15630301A IL156303A0 (en)	2000-12-06	2001-12-05	Method of collecting placental stem cells
IL156303A IL156303A (en)	2000-12-06	2003-06-04	Method of collecting placental stem cells from a post-partum human placenta
IL208510A IL208510A (en)	2000-12-06	2010-10-06	A population of isolated nucleated placenta cells
IL213109A IL213109A (en)	2000-12-06	2011-05-24	Methods for exogenous cell proliferation in placental bioreactor

Family Applications After (3)

Application Number	Title	Priority Date	Filing Date
IL156303A IL156303A (en)	2000-12-06	2003-06-04	Method of collecting placental stem cells from a post-partum human placenta
IL208510A IL208510A (en)	2000-12-06	2010-10-06	A population of isolated nucleated placenta cells
IL213109A IL213109A (en)	2000-12-06	2011-05-24	Methods for exogenous cell proliferation in placental bioreactor

Country Status (13)

Country	Link
US (13)	US7045148B2 (da)
EP (5)	EP1349918B1 (da)
JP (1)	JP4294316B2 (da)
KR (2)	KR100915483B1 (da)
AU (2)	AU2020902A (da)
CA (2)	CA2678490A1 (da)
DK (1)	DK1349918T3 (da)
ES (1)	ES2522890T3 (da)
HK (1)	HK1252977A1 (da)
IL (4)	IL156303A0 (da)
MX (1)	MXPA03005014A (da)
WO (1)	WO2002046373A1 (da)
ZA (1)	ZA200304341B (da)

Families Citing this family (210)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000046349A1 (en) *	1999-02-04	2000-08-10	Technion Research & Development Foundation Ltd.	Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
US10638734B2 (en)	2004-01-05	2020-05-05	Abt Holding Company	Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US8609412B2 (en) *	1999-08-05	2013-12-17	Regents Of The University Of Minnesota	Mapc generation of lung tissue
US7015037B1 (en) *	1999-08-05	2006-03-21	Regents Of The University Of Minnesota	Multiponent adult stem cells and methods for isolation
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
KR100915483B1 (ko) *	2000-12-06	2009-09-03	로버트 제이 하리리	태반 줄기 세포의 회수 방법
AU2007234581B2 (en) *	2001-02-14	2012-02-02	Celularity Inc.	Post-partum mammalian placenta, its use and placental stem cells therefrom
ES2545899T3 (es) *	2001-02-14	2015-09-16	Anthrogenesis Corporation	Placenta post-parto de mamíferos, su uso y células madre placentarias de la misma
JP2004528021A (ja) *	2001-02-14	2004-09-16	アンスロジェネシスコーポレーション	分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
IL157332A0 (en) *	2001-02-14	2004-02-19		Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US6942802B2 (en) *	2001-04-13	2005-09-13	Wyeth Holdings Corporation	Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
CA2468171C (en) *	2001-11-15	2015-10-06	Children's Medical Center Corporation	Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
NZ579705A (en) *	2002-02-13	2011-07-29	Anthrogenesis Corp	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
MXPA04007732A (es) *	2002-02-13	2004-10-15	Anthrogenesis Corp	Celulas madre similares a las embrionarias, derivadas de la placenta de mamiferos despues del parto y usos y metodos de tratamiento usando dichas celulas.
US7682803B2 (en)	2005-10-13	2010-03-23	Anthrogenesis Corporation	Immunomodulation using placental stem cells
AU2003262187A1 (en) *	2002-04-12	2003-10-27	Celgene Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
CA2481387A1 (en) *	2002-04-12	2003-10-23	Celgene Corporation	Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US7393862B2 (en)	2002-05-17	2008-07-01	Celgene Corporation	Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
JP2005528105A (ja) *	2002-05-30	2005-09-22	セルジーン・コーポレーション	細胞分化をモジュレートするため、並びに骨髄増殖性疾患及び骨髄異形成症候群を治療するためのｊｎｋ又はｍｋｋ阻害剤の使用方法
US20040171147A1 (en)	2002-11-26	2004-09-02	Hariri Robert J.	Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US20060228798A1 (en)	2002-11-27	2006-10-12	Catherine Verfaillie	Homologous recombination in multipotent adult progenitor cells
JP2007525193A (ja) *	2003-05-29	2007-09-06	ボードオブリージェンツザユニヴァーシティオブテキサスシステム	臨床用及び商用幹細胞
US9572840B2 (en)	2003-06-27	2017-02-21	DePuy Synthes Products, Inc.	Regeneration and repair of neural tissue using postpartum-derived cells
US8518390B2 (en)	2003-06-27	2013-08-27	Advanced Technologies And Regenerative Medicine, Llc	Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
US9592258B2 (en)	2003-06-27	2017-03-14	DePuy Synthes Products, Inc.	Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
ATE510005T1 (de) *	2003-06-27	2011-06-15	Univ Laval	Verfahren zur isolierung von zellen aus der nabelschnur
US8491883B2 (en)	2003-06-27	2013-07-23	Advanced Technologies And Regenerative Medicine, Llc	Treatment of amyotrophic lateral sclerosis using umbilical derived cells
EP1641915B1 (en)	2003-06-27	2016-07-27	DePuy Synthes Products, Inc.	Repair and regeneration of ocular tissue using postpartum-derived cells
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US8790637B2 (en)	2003-06-27	2014-07-29	DePuy Synthes Products, LLC	Repair and regeneration of ocular tissue using postpartum-derived cells
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
KR20120039065A (ko) *	2003-12-02	2012-04-24	셀진 코포레이션	혈색소병증　및　빈혈의　치료　및　관리를　위한　방법및　조성물
US7534606B2 (en) *	2004-01-12	2009-05-19	National Health Research Institutes	Placental stem cell and methods thereof
JP2007531116A (ja)	2004-03-26	2007-11-01	セルジーン・コーポレーション	幹細胞バンクを提供するためのシステム及び方法
CA2563518C (en) *	2004-04-23	2014-09-02	Bioe, Inc.	Multi-lineage progenitor cells
US7622108B2 (en) *	2004-04-23	2009-11-24	Bioe, Inc.	Multi-lineage progenitor cells
US8741555B2 (en) *	2004-05-14	2014-06-03	Organ Recovery Systems, Inc.	Apparatus and method for perfusion and determining the viability of an organ
BRPI0511287A (pt)	2004-05-17	2007-12-04	Univ Minnesota	uso de células-tronco do sangue do cordão umbilical para tratar evento isquêmico
EP1833496B1 (en)	2004-12-23	2013-07-31	Ethicon, Incorporated	Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
ES2621847T3 (es)	2004-12-23	2017-07-05	DePuy Synthes Products, Inc.	Células posparto derivadas de tejido de cordón umbilical, y métodos de elaboración y uso de las mismas
GB0503918D0 (en) *	2005-02-25	2005-04-06	Erasmus University	Cell
WO2006106823A1 (ja) *	2005-03-31	2006-10-12	Japan Science And Technology Agency	分子マーカーを用いた間葉系幹細胞の識別方法及びその利用
US8153430B2 (en) *	2005-03-31	2012-04-10	Stemnion, Inc.	Methods related to surgery
AU2006265601A1 (en) *	2005-06-30	2007-01-11	Anthrogenesis Corporation	Repair of tympanic membrane using placenta derived collagen biofabric
US20070021762A1 (en) *	2005-07-13	2007-01-25	Qing Liu	Ocular plug formed from placenta derived collagen biofabric
EP1919500A2 (en) *	2005-07-13	2008-05-14	Anthrogenesis Corporation	Treatment of leg ulcers using placenta derived collagen biofabric
US20070059824A1 (en) *	2005-09-12	2007-03-15	Yong Zhao	Human umbilical cord blood-derived pluripotent fibroblast-like-macrophages
US9388382B2 (en) *	2005-10-05	2016-07-12	The Board Of Trustees Of The University Of Illinois	Isolation of CD14 negative, CD45 positive and CD117 positive embryonic-like stem cells free of monocytes from human umbilical cord blood mononuclear cells
EP1941031B1 (en)	2005-10-05	2013-12-25	The Board Of Trustees Of The University Of Illinois	Isolated embryonic-like stem cells derived from human umbilical cord blood
WO2008048671A1 (en) *	2006-10-18	2008-04-24	University Of Illinois	Embryonic-like stem cells derived from adult human peripheral blood and methods of use
WO2007047465A1 (en)	2005-10-13	2007-04-26	Anthrogenesis Corporation	Production of oligodendrocytes from placenta-derived stem cells
EP1941032A2 (en) *	2005-10-14	2008-07-09	Regents Of The University Of Minnesota	Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
US10176887B1 (en) *	2005-11-14	2019-01-08	Organ Recovery Systems, Inc.	Ex vivo methods for drug discovery, development and testing
JP5289970B2 (ja)	2005-12-16	2013-09-11	エシコン・インコーポレイテッド	組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
WO2007073552A1 (en)	2005-12-19	2007-06-28	Ethicon, Inc.	In vitro expansion of postpartum derived cells in roller bottles
EP1979050B1 (en) *	2005-12-28	2017-04-19	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using postpartum-derived cells
US9125906B2 (en)	2005-12-28	2015-09-08	DePuy Synthes Products, Inc.	Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
JP2009521931A (ja)	2005-12-29	2009-06-11	アントフロゲネシスコーポレーション	胎盤幹細胞を収集及び保存するための改善された組成物、及び該組成物の使用方法
AU2006332679A1 (en)	2005-12-29	2007-07-12	Anthrogenesis Corporation	Co-culture of placental stem cells and stem cells from a second source
PT2471905T (pt)	2005-12-29	2019-01-11	Celularity Inc	Populações de células estaminais placentárias
US9944900B2 (en) *	2006-01-18	2018-04-17	Hemacell Perfusion	Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells
US8871198B2 (en) *	2006-03-29	2014-10-28	Stemnion, Inc.	Methods related to wound healing
CA2646384C (en) *	2006-03-23	2020-03-24	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
US20110171182A1 (en) *	2006-03-23	2011-07-14	Pluristem Ltd.	Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
WO2007121443A2 (en) *	2006-04-17	2007-10-25	Bioe, Inc.	Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
CN105087490A (zh) *	2006-05-11	2015-11-25	脐血科技公司	收集和使用胎盘脐血干细胞的方法
EP2035093A4 (en)	2006-06-14	2010-02-17	Stemnion Inc	METHODS FOR TREATING SPINAL CORD INJURY AND MINIMIZING THE SCALING SCALE
US7993918B2 (en)	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US8105634B2 (en) *	2006-08-15	2012-01-31	Anthrogenesis Corporation	Umbilical cord biomaterial for medical use
US8372437B2 (en)	2006-08-17	2013-02-12	Mimedx Group, Inc.	Placental tissue grafts
US20080131522A1 (en) *	2006-10-03	2008-06-05	Qing Liu	Use of placental biomaterial for ocular surgery
US8071135B2 (en)	2006-10-04	2011-12-06	Anthrogenesis Corporation	Placental tissue compositions
CA2665369C (en)	2006-10-06	2023-01-10	Anthrogenesis Corporation	Human placental collagen compositions, and methods of making and using the same
CN101631852A (zh)	2006-10-23	2010-01-20	人类起源公司	用胎盘细胞群治疗骨缺损的方法和组合物
EP2118267B1 (en)	2007-01-17	2017-03-15	Noveome Biotherapeutics, Inc.	Novel methods for modulating inflammatory and/or immune responses
RS52921B (sr)	2007-02-12	2014-02-28	Anthrogenesis Corporation	Lečenje inflamatornih bolesti upotrebom placentnih matičnih ćelija
US10494607B2 (en)	2007-02-12	2019-12-03	Celularity, Inc.	CD34+,CD45−placental stem cell-enriched cell populations
US8673547B2 (en) *	2007-03-08	2014-03-18	Hemacell Perfusion, Inc.	Method for isolation of afterbirth derived cells
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
EP2607477B1 (en)	2007-05-03	2020-09-23	The Brigham and Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8574567B2 (en)	2007-05-03	2013-11-05	The Brigham And Women's Hospital, Inc.	Multipotent stem cells and uses thereof
US8765364B2 (en) *	2007-05-18	2014-07-01	Lifeline Scientific, Inc.	Ex vivo methods for validating substance testing with human organs and/or tissues
US8771930B2 (en) *	2007-05-18	2014-07-08	Lifeline Scientific, Inc.	Ex vivo methods for testing toxicity of substances using donated human organs or tissues
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
KR100900309B1 (ko) *	2007-05-29	2009-06-02	차의과학대학교 산학협력단	태반 융모막판막-유래 중간엽 줄기 세포의 고순도 분리방법
CA2688504A1 (en) *	2007-06-18	2008-12-24	Children's Hospital & Research Center At Oakland	Method of isolating stem and progenitor cells from placenta
WO2009015343A2 (en) *	2007-07-25	2009-01-29	Bioe, Inc.	Differentiation of multi-lineage progenitor cells to chondrocytes
WO2009017655A2 (en) *	2007-07-27	2009-02-05	Immuneregen Biosciences, Inc.	Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance p or an analog thereof
US9200253B1 (en)	2007-08-06	2015-12-01	Anthrogenesis Corporation	Method of producing erythrocytes
EP2197270B8 (en)	2007-09-07	2020-03-04	Surgical Biologics, LLC	Placental tissue grafts and improved methods of preparing and using the same
RU2010109698A (ru) *	2007-09-19	2011-09-27	Плуристем Лтд. (Il)	Адгезивные клетки жировой ткани или плаценты и их использование в лечебных целях
MX2010003217A (es) *	2007-09-26	2010-07-30	Celgene Cellular Therapeutics	Celulas angiogenicas de perfundido de placenta humana.
CA2700617C (en)	2007-09-28	2018-11-06	Celgene Cellular Therapeutics	Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
JP5323845B2 (ja)	2007-10-05	2013-10-23	エシコン・インコーポレイテッド	ヒト臍帯組織由来細胞を用いた腎組織の修復および再建
DK2217329T3 (da)	2007-11-07	2018-04-23	Anthrogenesis Corp	Anvendelse af navlestrengsblod i behandlingen af komplikationer i forbindelse med præterm fødsel
US8236538B2 (en)	2007-12-20	2012-08-07	Advanced Technologies And Regenerative Medicine, Llc	Methods for sterilizing materials containing biologically active agents
CN101978047A (zh) *	2008-01-18	2011-02-16	明尼苏达大学董事会	干细胞聚集体及制备和使用方法
EP2271209B1 (en) *	2008-03-27	2016-07-13	Biolife Solutions, Inc.	Materials and methods for hypothermic collection of whole blood
US20090291494A1 (en) *	2008-05-21	2009-11-26	Bioe, Inc.	Differentiation of Multi-Lineage Progenitor Cells to Pancreatic Cells
CN105766891A (zh)	2008-08-20	2016-07-20	人类起源公司	改进的细胞组合物及制备所述组合物的方法
CN105796602A (zh)	2008-08-20	2016-07-27	人类起源公司	利用分离的胎盘细胞治疗中风
CA2965883C (en)	2008-08-22	2020-05-12	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
EP2334783B1 (en)	2008-09-02	2016-06-22	Pluristem Ltd.	Adherent cells from placenta tissue and use thereof in therapy
WO2010049752A1 (en)	2008-10-31	2010-05-06	Katholieke Universiteit Leuven	Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells
ES2749500T3 (es)	2008-11-19	2020-03-20	Celularity Inc	Células adherentes derivadas del amnios
RU2732240C2 (ru) *	2008-11-21	2020-09-14	Антродженезис Корпорейшн	Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток
US10557116B2 (en)	2008-12-19	2020-02-11	DePuy Synthes Products, Inc.	Treatment of lung and pulmonary diseases and disorders
US10179900B2 (en)	2008-12-19	2019-01-15	DePuy Synthes Products, Inc.	Conditioned media and methods of making a conditioned media
US8771677B2 (en) *	2008-12-29	2014-07-08	Vladimir B Serikov	Colony-forming unit cell of human chorion and method to obtain and use thereof
CA2756594C (en)	2009-03-25	2021-03-23	Anthrogenesis Corporation	Treatment of viral infection using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
SG174551A1 (en)	2009-03-26	2011-10-28	Ethicon Inc	Human umbilical cord tissue cells as therapy for alzheimer' s disease
RU2412993C2 (ru) *	2009-03-30	2011-02-27	Федеральное государственное учреждение высшего профессионального образования Волгоградская государственная сельскохозяйственная академия	Способ получения крови с наличием гемопоэтических и стромальных стволовых клеток от плодов-телят
WO2010141654A1 (en)	2009-06-05	2010-12-09	Anthrogenesis Corporation	Improved method of collecting placental cells
US8796315B2 (en)	2009-06-25	2014-08-05	Darlene E. McCord	Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
EP2449095A1 (en)	2009-07-02	2012-05-09	Anthrogenesis Corporation	Method of producing erythrocytes without feeder cells
CN104962512B (zh) *	2009-07-21	2022-09-09	Abt控股公司	干细胞用于减少白细胞外渗的用途
CA2768573C (en) *	2009-07-21	2020-09-15	Abt Holding Company	A method for constructing a cell bank and a method for drug discovery
USRE47996E1 (en)	2009-10-09	2020-05-19	Ethicon Llc	Surgical generator for ultrasonic and electrosurgical devices
US9121007B2 (en)	2010-01-26	2015-09-01	Anthrogenesis Corporatin	Treatment of bone-related cancers using placental stem cells
US8956327B2 (en)	2010-02-08	2015-02-17	Access Scientific, Llc	Access device
WO2011106476A1 (en) *	2010-02-25	2011-09-01	Abt Holding Company	Modulation of microglia activation
US20110206647A1 (en) *	2010-02-25	2011-08-25	Abt Holding Company	Modulation of Angiogenesis
EP2556145B1 (en)	2010-04-07	2016-07-20	Anthrogenesis Corporation	Angiogenesis using placental stem cells
MX2012011543A (es) *	2010-04-08	2013-05-06	Anthrogenesis Corp	Tratamiento de sarcoidosis empleando celulas madre placentarias.
SG185526A1 (en)	2010-05-12	2012-12-28	Abt Holding Co	Modulation of splenocytes in cell therapy
US9090878B2 (en)	2010-06-17	2015-07-28	Katholieke Universiteit Leuven	Methods for differentiating cells into hepatic stellate cells and hepatic sinusoidal endothelial cells, cells produced by the methods, and methods for using the cells
JP5996533B2 (ja)	2010-07-13	2016-09-21	アントフロゲネシスコーポレーション	ナチュラルキラー細胞を生成させる方法
CN103237886B (zh)	2010-08-24	2018-10-30	明尼苏达大学董事会	细胞集合体的非静态悬浮培养
US8574899B2 (en)	2010-12-22	2013-11-05	Vladimir B Serikov	Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
US20120171180A1 (en)	2010-12-30	2012-07-05	Sascha Abramson	Compositions comprising amnion derived adherent cells and platelet-rich plasma
WO2012092458A2 (en)	2010-12-30	2012-07-05	Anthrogenesis Corporation	Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
WO2012092485A1 (en)	2010-12-31	2012-07-05	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory rna molecules
CA2826433C (en)	2011-02-14	2022-05-31	Brenda S. Morse	Micronized placental tissue compositions and methods of making and using the same
AU2012217982B2 (en)	2011-02-14	2016-05-12	Mimedx Group Inc.	Tissue grafts modified with a cross-linking agent and method of making and using the same
KR101835917B1 (ko)	2011-03-22	2018-03-07	플루리스템 리미티드	방사선 또는 화학적 손상을 치료하는 방법들
WO2012166844A2 (en)	2011-06-01	2012-12-06	Anthrogenesis Corporation	Treatment of pain using placental stem cells
US10190092B2 (en)	2011-08-11	2019-01-29	Robert A. Dracker	Procurement of placental stem cells
WO2013023212A2 (en) *	2011-08-11	2013-02-14	Dracker Robert A	Procurement of placental stem cells
WO2013055476A1 (en)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Treatment of amyotrophic lateral sclerosis using placental stem cells
US12290613B2 (en)	2011-10-06	2025-05-06	Mimedx Group, Inc.	Micronized compositions composed of bone grafts and methods of making and using the same
US20140294840A1 (en)	2011-11-30	2014-10-02	University Of Bremen	Expression of mirnas in placental tissue
US9526478B2 (en) *	2011-12-22	2016-12-27	The Johns Hopkins University	Cord blood perfusion and collection system
JP6254094B2 (ja)	2011-12-22	2017-12-27	ミメディクスグループインコーポレイテッド	架橋脱水された胎盤組織移植片ならびにそれを作製および使用する方法
BR112014015424A2 (pt)	2011-12-23	2018-05-22	Depuy Synthes Products Llc	detecção de células derivadas de tecido do cordão umbilical humano
US8940294B2 (en)	2012-03-02	2015-01-27	Tissuetech, Inc.	Methods of isolating and culturing stem cells
CN102618438A (zh) *	2012-04-11	2012-08-01	章毅	用于脐带血干细胞的检测和筛查系统
KR20220166873A (ko)	2012-08-13	2022-12-19	셀룰래리티 인코포레이티드	자연 살해 세포 및 그의 용도
US11338063B2 (en)	2012-08-15	2022-05-24	Mimedx Group, Inc.	Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
EP2884944B1 (en)	2012-08-15	2020-10-07	MiMedx Group, Inc.	Reinforced placental tissue grafts and methods of making and using the same
US8904664B2 (en)	2012-08-15	2014-12-09	Mimedx Group, Inc.	Dehydration device and methods for drying biological materials
US9943551B2 (en)	2012-08-15	2018-04-17	Mimedx Group, Inc.	Tissue grafts composed of micronized placental tissue and methods of making and using the same
HK1212261A1 (en) *	2012-09-04	2016-06-10	人类起源公司	Methods of tissue generation
US9180145B2 (en)	2012-10-12	2015-11-10	Mimedx Group, Inc.	Compositions and methods for recruiting and localizing stem cells
US8946163B2 (en)	2012-11-19	2015-02-03	Mimedx Group, Inc.	Cross-linked collagen comprising metallic anticancer agents
US9155799B2 (en)	2012-11-19	2015-10-13	Mimedx Group, Inc.	Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent
US9144555B2 (en)	2012-11-30	2015-09-29	Darlene E. McCord	Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition
CA2894160C (en)	2012-12-07	2024-01-02	Anthrogenesis Corporation	Treating oral lesions using placental extracellular matrix
WO2014093753A1 (en)	2012-12-14	2014-06-19	Anthrogenesis Corporation	Anoikis resistant placental stem cells and uses thereof
AU2013204922B2 (en)	2012-12-20	2015-05-14	Celgene Corporation	Chimeric antigen receptors
US9827293B2 (en)	2013-01-17	2017-11-28	Mimedx Group, Inc.	Non-surgical, localized delivery of compositions for placental growth factors
US10517931B2 (en)	2013-01-17	2019-12-31	Mimedx Group, Inc.	Non-surgical, localized delivery of compositions for placental growth factors
US9655948B1 (en)	2013-01-17	2017-05-23	Mimedx Group, Inc.	Non-surgical, localized delivery of compositions for placental growth factors
US10206977B1 (en)	2013-01-18	2019-02-19	Mimedx Group, Inc.	Isolated placental stem cell recruiting factors
JP6545102B2 (ja)	2013-01-18	2019-07-17	ミメディクスグループインコーポレイテッド	心病態を治療する方法
CN115137753A (zh)	2013-02-05	2022-10-04	细胞结构公司	来自胎盘的自然杀伤细胞
EP2968402B1 (en)	2013-03-13	2020-07-15	Noveome Biotherapeutics, Inc.	Medical device having a coating comprising accs
US10329529B2 (en)	2013-03-14	2019-06-25	Celularity, Inc.	Enhanced placental stem cells and uses thereof
NO2975611T3 (da)	2013-03-15	2018-06-09
JP2016509863A (ja)	2013-03-15	2016-04-04	ラーソン、マルクスカーレ、トールレイフＬＡＲＳＳＯＮ，ＭａｒｃｕｓＫａｒｅ，Ｔｏｒｌｅｉｆ	細胞、臍帯血収集のための方法及び装置、並びに細胞の単離のための方法及び装置
US10029030B2 (en)	2013-03-15	2018-07-24	Mimedx Group, Inc.	Molded placental tissue compositions and methods of making and using the same
US9839632B2 (en)	2013-04-02	2017-12-12	Celgene Corporation	Methods and compositions using 4-amino-2-(2,6-dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment and management of central nervous system cancers
CA2909267C (en)	2013-04-12	2022-10-25	Saverio LA FRANCESCA	Improving organs for transplantation
US9446142B2 (en)	2013-05-28	2016-09-20	Mimedx Group, Inc.	Polymer chelator conjugates
EP3862422A1 (en)	2013-06-24	2021-08-11	Celularity Inc.	Extracellular matrix composition beads for cell culture
KR20160098244A (ko)	2013-11-15	2016-08-18	안트로제네시스 코포레이션	사람 태반 관류액 세포를 포함하는 조성물, 상기 세포의 부분모집단 및 이의 용도
JP7099822B2 (ja)	2014-08-28	2022-07-12	ミメディクスグループインコーポレイテッド	コラーゲンで強化した組織移植片
RU2644650C2 (ru)	2014-12-01	2018-02-13	Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии"	Материал стволовых клеток и способ его получения
CA2972806A1 (en)	2014-12-31	2016-07-07	Anthrogenesis Corporation	Methods of treating hematological disorders, solid tumors, or infectious diseases using natural killer cells
KR101766450B1 (ko) *	2015-04-30	2017-08-08	주식회사 싸이토젠	표적 세포 회수 방법
IL281185B2 (en)	2015-09-15	2024-05-01	Celularity Inc	Treatment of diabetic peripheral neuropathy using placental cells
WO2017127123A1 (en)	2016-01-21	2017-07-27	Abt Holding Company	Stem cells for wound healing
RU2708329C2 (ru)	2016-05-31	2019-12-05	Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии"	Материал стволовых клеток, композиции и способы применения
US10426796B2 (en)	2016-06-13	2019-10-01	SMART SURGICAL, Inc.	Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en)	2016-06-13	2019-10-29	SMART SURGICAL, Inc.	Compositions for biological systems and methods for preparing and using the same
WO2018013693A1 (en)	2016-07-13	2018-01-18	Celgene Corporation	Solid dispersions and cocrystals comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione compositions and methods of use thereof
KR101890856B1 (ko) *	2016-09-13	2018-08-23	사회복지법인 삼성생명공익재단	중간엽 줄기세포 또는 ＡｇＲＰ를 포함하는 유비퀴틴 프로테아좀 활성 증가를 통한 퇴행성 뇌질환 치료제
WO2018052182A1 (ko) *	2016-09-13	2018-03-22	사회복지법인 삼성생명공익재단	중간엽 줄기세포 또는 ＡｇＲＰ를 포함하는 유비퀴틴 프로테아좀 활성 증가를 통한 퇴행성 뇌질환 치료제
US11542473B2 (en)	2016-10-21	2023-01-03	Amniotics Ab	Methods and compositions for generating hematopoietic cells
MX2019006514A (es)	2016-12-05	2019-10-30	Celularity Inc	Tratamiento de linfedema y afecciones relacionadas a través del uso de las células adherentes placentarias.
EP3655061A4 (en) *	2017-07-21	2021-07-28	Theracord LLC	CANNULA FIXING DEVICE
US20200246393A1 (en)	2017-09-28	2020-08-06	Celularity, Inc.	Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibody
US20210095258A1 (en)	2018-02-22	2021-04-01	Celularity Inc.	Post partum tissue-derived induced pluripotent stem cells and uses thereof
CN113454207A (zh)	2018-11-30	2021-09-28	细胞结构公司	用新型芳香族化合物扩增自然杀伤细胞和ilc3细胞
WO2020252464A1 (en)	2019-06-14	2020-12-17	Celularity Inc.	Populations of natural killer cells for treating cancers
EP3986358A4 (en)	2019-06-20	2023-06-21	Amniotics AB	DEVICE FOR FILTERING FRUIT WATER
WO2021003257A1 (en) *	2019-07-01	2021-01-07	Auxocell Laboratories, Inc.	Methods and compositions for collecting and using placental tissue cells and placental blood cells
WO2021016621A1 (en)	2019-07-25	2021-01-28	Celularity Inc.	Populations of natural killer cells comprising a cd38 chimeric antigen receptor
US20230355759A1 (en)	2019-07-31	2023-11-09	Celularity Inc.	Populations of natural killer cells comprising a cleavage resistant cd16
EP4234019A3 (en)	2019-10-18	2023-09-13	Amniotics AB	Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof
RU2744519C1 (ru) *	2019-11-08	2021-03-11	Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации - Федеральный медицинский биофизический центр имени А.И. Бурзаняна Федерального медико-биологического агентства" (ФГБУ ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России)	Способ повышения эффективности комплексной терапии при местных лучевых поражениях
WO2021113849A1 (en)	2019-12-05	2021-06-10	Celularity Inc.	Her2+ cancer treatment with populations of natural killer cells comprising a cleavage resistant cd16
US20220000919A1 (en)	2020-01-29	2022-01-06	Celularity Inc.	Placental derived natural killer cells for treatment of coronavirus infections
WO2021226602A1 (en)	2020-05-08	2021-11-11	Celularity Inc.	Placenta-derived adherent (pda) stem cell for the treatment of adults with sars-cov-2 related acute respiratory failure and ards (covid-19)
US12435308B2 (en)	2020-11-06	2025-10-07	Amniotics Ab	Immunomodulation by amniotic fluid mesenchymal stem cells
WO2023278628A1 (en)	2021-06-29	2023-01-05	Celularity Inc.	Human placental hematopoietic stem cell derived natural killer cells in acute myeloid leukemia (aml) remission with minimal residual disease (mrd) or relapsed/refractory aml
WO2023010123A1 (en)	2021-07-29	2023-02-02	Celularity Inc.	Placenta-dervied nk cells as a senolytic for therapeutic and other uses
CA3231611A1 (en) *	2021-09-17	2023-03-23	Nenad SESTAN	Methods, systems and compositions for restoration and preservation of intact organs in a mammal
US20250295776A1 (en)	2022-01-11	2025-09-25	Celularity Inc.	Cleavage resistant cd16 constructs and uses thereof

Family Cites Families (232)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3862002A (en) *	1962-05-08	1975-01-21	Sanfar Lab Inc	Production of physiologically active placental substances
US3461645A (en) *	1965-10-22	1969-08-19	Harold I Snyder	Packaging machine
US4829000A (en) *	1985-08-30	1989-05-09	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Reconstituted basement membrane complex with biological activity
US5863531A (en)	1986-04-18	1999-01-26	Advanced Tissue Sciences, Inc.	In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework
US5902741A (en)	1986-04-18	1999-05-11	Advanced Tissue Sciences, Inc.	Three-dimensional cartilage cultures
US5192553A (en) *	1987-11-12	1993-03-09	Biocyte Corporation	Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5004681B1 (en) *	1987-11-12	2000-04-11	Biocyte Corp	Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
GB8803697D0 (en)	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
FR2646438B1 (fr)	1989-03-20	2007-11-02	Pasteur Institut	Procede de remplacement specifique d'une copie d'un gene present dans le genome receveur par l'integration d'un gene different de celui ou se fait l'integration
US5605822A (en)	1989-06-15	1997-02-25	The Regents Of The University Of Michigan	Methods, compositions and devices for growing human hematopoietic cells
US5635386A (en)	1989-06-15	1997-06-03	The Regents Of The University Of Michigan	Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
US5399493A (en) *	1989-06-15	1995-03-21	The Regents Of The University Of Michigan	Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5437994A (en)	1989-06-15	1995-08-01	Regents Of The University Of Michigan	Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5763266A (en)	1989-06-15	1998-06-09	The Regents Of The University Of Michigan	Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
DE69033493D1 (de)	1989-07-25	2004-08-12	Cell Genesys Inc	Homologe rekombination für universelle donorzellen und chimerische säugetierzellen
US5464764A (en)	1989-08-22	1995-11-07	University Of Utah Research Foundation	Positive-negative selection methods and vectors
EP0452484B2 (en)	1989-11-06	2004-07-28	Cell Genesys, Inc.	Production of proteins using homologous recombination
US5272071A (en)	1989-12-22	1993-12-21	Applied Research Systems Ars Holding N.V.	Method for the modification of the expression characteristics of an endogenous gene of a given cell line
US5061620A (en)	1990-03-30	1991-10-29	Systemix, Inc.	Human hematopoietic stem cell
US5635387A (en) *	1990-04-23	1997-06-03	Cellpro, Inc.	Methods and device for culturing human hematopoietic cells and their precursors
US6326198B1 (en)	1990-06-14	2001-12-04	Regents Of The University Of Michigan	Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5486359A (en)	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
US5226914A (en)	1990-11-16	1993-07-13	Caplan Arnold I	Method for treating connective tissue disorders
US5733542A (en)	1990-11-16	1998-03-31	Haynesworth; Stephen E.	Enhancing bone marrow engraftment using MSCS
US6010696A (en)	1990-11-16	2000-01-04	Osiris Therapeutics, Inc.	Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
US5197985A (en)	1990-11-16	1993-03-30	Caplan Arnold I	Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5837539A (en)	1990-11-16	1998-11-17	Osiris Therapeutics, Inc.	Monoclonal antibodies for human mesenchymal stem cells
US5811094A (en)	1990-11-16	1998-09-22	Osiris Therapeutics, Inc.	Connective tissue regeneration using human mesenchymal stem cell preparations
WO1992014455A1 (en) *	1991-02-14	1992-09-03	The Rockefeller University	METHOD FOR CONTROLLING ABNORMAL CONCENTRATION TNF α IN HUMAN TISSUES
US5190556A (en) *	1991-03-19	1993-03-02	O.B. Tech, Inc.	Cord cutter sampler
US5744361A (en)	1991-04-09	1998-04-28	Indiana University	Expansion of human hematopoietic progenitor cells in a liquid medium
AU2515992A (en)	1991-08-20	1993-03-16	Genpharm International, Inc.	Gene targeting in animal cells using isogenic dna constructs
US5356373A (en)	1991-11-15	1994-10-18	Miles Inc.	Method and apparatus for autologous transfusions in premature infants
AU679436B2 (en)	1991-12-23	1997-07-03	British Bio-Technology Limited	Stem cell inhibiting proteins
CA2110283A1 (en)	1992-03-31	1993-10-14	Tatsutoshi Nakahata	Physiologically active protein and hemotopoietic stem cell growth agent
US5460964A (en)	1992-04-03	1995-10-24	Regents Of The University Of Minnesota	Method for culturing hematopoietic cells
AU4543193A (en) *	1992-06-22	1994-01-24	Henry E. Young	Scar inhibitory factor and use thereof
US5849553A (en)	1992-07-27	1998-12-15	California Institute Of Technology	Mammalian multipotent neural stem cells
US5693482A (en)	1992-07-27	1997-12-02	California Institute Of Technology	Neural chest stem cell assay
US5672346A (en)	1992-07-27	1997-09-30	Indiana University Foundation	Human stem cell compositions and methods
WO1994011493A1 (en)	1992-11-16	1994-05-26	Applied Immune Sciences, Inc.	Pluripotential quiescent stem cell population
US5772992A (en)	1992-11-24	1998-06-30	G.D. Searle & Co.	Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US5654186A (en)	1993-02-26	1997-08-05	The Picower Institute For Medical Research	Blood-borne mesenchymal cells
WO1994022915A1 (en)	1993-03-31	1994-10-13	Pro-Neuron, Inc.	Inhibitor of stem cell proliferation and uses thereof
GB9308271D0 (en)	1993-04-21	1993-06-02	Univ Edinburgh	Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
US5709854A (en)	1993-04-30	1998-01-20	Massachusetts Institute Of Technology	Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5372581A (en) *	1993-07-21	1994-12-13	Minneapolis Children's Services Corporation	Method and apparatus for placental blood collection
US5591625A (en)	1993-11-24	1997-01-07	Case Western Reserve University	Transduced mesenchymal stem cells
US6288030B1 (en)	1993-12-22	2001-09-11	Amgen Inc.	Stem cell factor formulations and methods
US6001654A (en)	1994-01-28	1999-12-14	California Institute Of Technology	Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
US5942496A (en)	1994-02-18	1999-08-24	The Regent Of The University Of Michigan	Methods and compositions for multiple gene transfer into bone cells
US6174333B1 (en)	1994-06-06	2001-01-16	Osiris Therapeutics, Inc.	Biomatrix for soft tissue regeneration using mesenchymal stem cells
ATE247933T1 (de)	1994-06-06	2003-09-15	Univ Case Western Reserve	Biomatrix für geweberegenaration
DE4422667A1 (de) *	1994-06-30	1996-01-04	Boehringer Ingelheim Int	Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
US6103522A (en)	1994-07-20	2000-08-15	Fred Hutchinson Cancer Research Center	Human marrow stromal cell lines which sustain hematopoiesis
US5516532A (en)	1994-08-05	1996-05-14	Children's Medical Center Corporation	Injectable non-immunogenic cartilage and bone preparation
US5827742A (en)	1994-09-01	1998-10-27	Beth Israel Deaconess Medical Center, Inc.	Method of selecting pluripotent hematopioetic progenitor cells
US5665557A (en) *	1994-11-14	1997-09-09	Systemix, Inc.	Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
JP3600244B2 (ja)	1994-11-16	2004-12-15	アムジエン・インコーポレーテツド	造血系多能性細胞のｅｘｖｉｖｏ増殖のための幹細胞因子および可溶性インターロイキン−６受容体の使用
US5914268A (en) *	1994-11-21	1999-06-22	National Jewish Center For Immunology & Respiratory Medicine	Embryonic cell populations and methods to isolate such populations
US5874301A (en) *	1994-11-21	1999-02-23	National Jewish Center For Immunology And Respiratory Medicine	Embryonic cell populations and methods to isolate such populations
US5789147A (en) *	1994-12-05	1998-08-04	New York Blood Center, Inc.	Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
US5736396A (en)	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
US5695998A (en) *	1995-02-10	1997-12-09	Purdue Research Foundation	Submucosa as a growth substrate for islet cells
US6011000A (en)	1995-03-03	2000-01-04	Perrine; Susan P.	Compositions for the treatment of blood disorders
US5906934A (en)	1995-03-14	1999-05-25	Morphogen Pharmaceuticals, Inc.	Mesenchymal stem cells for cartilage repair
US5716616A (en)	1995-03-28	1998-02-10	Thomas Jefferson University	Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects
AU5564996A (en) *	1995-04-19	1996-11-07	St. Jude Medical Inc.	Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US5733541A (en)	1995-04-21	1998-03-31	The Regent Of The University Of Michigan	Hematopoietic cells: compositions and methods
CZ289896B6 (cs)	1995-04-27	2002-04-17	The Procter & Gamble Company	Nosič upravený pomocí inverzní emulze s vysokým obsahem vnitřní vodní fáze, připravené za uľití organopolysiloxan-polyoxyalkylenového emulgátoru
US5925567A (en)	1995-05-19	1999-07-20	T. Breeders, Inc.	Selective expansion of target cell populations
US5908782A (en)	1995-06-05	1999-06-01	Osiris Therapeutics, Inc.	Chemically defined medium for human mesenchymal stem cells
US5830708A (en)	1995-06-06	1998-11-03	Advanced Tissue Sciences, Inc.	Methods for production of a naturally secreted extracellular matrix
WO1996040875A1 (en)	1995-06-07	1996-12-19	Novartis Ag	Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
US5877299A (en)	1995-06-16	1999-03-02	Stemcell Technologies Inc.	Methods for preparing enriched human hematopoietic cell preparations
US5654381A (en)	1995-06-16	1997-08-05	Massachusetts Institute Of Technology	Functionalized polyester graft copolymers
US6306575B1 (en)	1995-06-16	2001-10-23	Stemcell Technologies, Inc.	Methods for preparing enriched human hematopoietic cell preparations
US5935576A (en)	1995-09-13	1999-08-10	Fordham University	Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US5858782A (en)	1995-11-13	1999-01-12	Regents Of The University Of Michigan	Functional human hematopoietic cells
WO1997018298A1 (en)	1995-11-14	1997-05-22	Regents Of The University Of Minnesota	Ex vivo culture of stem cells
WO1997018299A1 (en)	1995-11-16	1997-05-22	Case Western Reserve University	In vitro chondrogenic induction of human mesenchymal stem cells
US6337387B1 (en)	1995-11-17	2002-01-08	Asahi Kasei Kabushiki Kaisha	Differentiation-suppressive polypeptide
GB9600082D0 (en) *	1996-01-04	1996-03-06	Exxon Chemical Patents Inc	Molecular sieves and processes for their manufacture
US5716794A (en)	1996-03-29	1998-02-10	Xybernaut Corporation	Celiac antigen
CA2251983C (en)	1996-04-19	2003-12-16	Sudhakar Kadiyala	Regeneration and augmentation of bone using mesenchymal stem cells
US6455678B1 (en)	1996-04-26	2002-09-24	Amcell Corporation	Human hematopoietic stem and progenitor cell antigen
JP2000508922A (ja)	1996-04-26	2000-07-18	ケースウエスターンリザーブユニバーシティ	間葉幹細胞を用いる皮膚再生
US5919176A (en)	1996-05-14	1999-07-06	Children's Hospital Medical Center Of Northern California	Apparatus and method for collecting blood from an umbilical cord
US5827740A (en)	1996-07-30	1998-10-27	Osiris Therapeutics, Inc.	Adipogenic differentiation of human mesenchymal stem cells
US5851984A (en)	1996-08-16	1998-12-22	Genentech, Inc.	Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
US5916202A (en) *	1996-08-30	1999-06-29	Haswell; John N.	Umbilical cord blood collection
US6227202B1 (en)	1996-09-03	2001-05-08	Maulana Azad Medical College	Method of organogenesis and tissue regeneration/repair using surgical techniques
US5945337A (en)	1996-10-18	1999-08-31	Quality Biological, Inc.	Method for culturing CD34+ cells in a serum-free medium
US5919702A (en)	1996-10-23	1999-07-06	Advanced Tissue Science, Inc.	Production of cartilage tissue using cells isolated from Wharton's jelly
US5969105A (en)	1996-10-25	1999-10-19	Feng; Yiqing	Stem cell factor receptor agonists
US6335195B1 (en)	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US6152142A (en)	1997-02-28	2000-11-28	Tseng; Scheffer C. G.	Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US6231880B1 (en)	1997-05-30	2001-05-15	Susan P. Perrine	Compositions and administration of compositions for the treatment of blood disorders
DE69837491T2 (de)	1997-07-03	2008-01-17	Osiris Therapeutics, Inc.	Menschliche mesenchymale stammzellen aus peripherem blut
CA2296704C (en)	1997-07-14	2010-10-19	Osiris Therapeutics, Inc.	Cardiac muscle regeneration using mesenchymal stem cells
US7514074B2 (en)	1997-07-14	2009-04-07	Osiris Therapeutics, Inc.	Cardiac muscle regeneration using mesenchymal stem cells
US6077708A (en)	1997-07-18	2000-06-20	Collins; Paul C.	Method of determining progenitor cell content of a hematopoietic cell culture
US5879318A (en) *	1997-08-18	1999-03-09	Npbi International B.V.	Method of and closed system for collecting and processing umbilical cord blood
AU9127098A (en)	1997-09-04	1999-03-22	Osiris Therapeutics, Inc.	Ligands that modulate differentiation of mesenchymal stem cells
US5968829A (en)	1997-09-05	1999-10-19	Cytotherapeutics, Inc.	Human CNS neural stem cells
US6093531A (en)	1997-09-29	2000-07-25	Neurospheres Holdings Ltd.	Generation of hematopoietic cells from multipotent neural stem cells
WO1999020741A1 (en) *	1997-10-23	1999-04-29	Geron Corporation	Methods and materials for the growth of primate-derived primordial stem cells
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6059968A (en) *	1998-01-20	2000-05-09	Baxter International Inc.	Systems for processing and storing placenta/umbilical cord blood
ATE286118T1 (de)	1998-03-13	2005-01-15	Osiris Therapeutics Inc	Anwendungen für humane nicht autologe, mesenchymale stammzellen
US6368636B1 (en)	1998-03-18	2002-04-09	Osiris Therapeutics, Inc.	Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
WO1999047163A2 (en)	1998-03-18	1999-09-23	Osiris Therapeutics, Inc.	Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
PT1066060E (pt)	1998-04-03	2003-12-31	Osiris Therapeutics Inc	Celulas estaminais mesenquimais como imunossupressores
AU770319C (en)	1998-05-04	2004-11-25	Point Therapeutics, Inc.	Hematopoietic stimulation
EP1096941B1 (en) *	1998-05-07	2005-08-10	University Of South Florida	Bone marrow cells as a source of neurons for brain and spinal cord repair
US6835377B2 (en)	1998-05-13	2004-12-28	Osiris Therapeutics, Inc.	Osteoarthritis cartilage regeneration
CA2328425A1 (en)	1998-05-22	1999-12-02	Osiris Therapeutics, Inc.	Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
DE69936720T2 (de)	1998-05-29	2008-04-30	Osiris Therapeutics, Inc.	Menschliche cd45+ und/oder fibroblasten+ mesenchymale stammzellen
AU4336499A (en) *	1998-06-08	1999-12-30	Osiris Therapeutics, Inc.	Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
JP4526186B2 (ja)	1998-06-08	2010-08-18	オシリスセラピューティクス，インコーポレイテッド	造血幹細胞を試験管内で維持する方法と組成物
US6713245B2 (en)	1998-07-06	2004-03-30	Diacrin, Inc.	Methods for storing neural cells such that they are suitable for transplantation
DE69813908T2 (de)	1998-07-28	2004-02-05	Synthes Ag Chur, Chur	Verwendung von kreatinsubstanzen zur behandlung von knochen- und knorpelzellen und geweben
US5958767A (en)	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
JP3517359B2 (ja)	1998-09-14	2004-04-12	テルモ株式会社	細胞分離・回収装置および細胞の分離・回収方法
WO2000017325A1 (en)	1998-09-23	2000-03-30	Mount Sinai Hospital	Trophoblast cell preparations
CN1180079C (zh)	1998-11-12	2004-12-15	基质细胞有限责任公司	在三维装置中从造血祖细胞产生淋巴组织-特异细胞
US6184035B1 (en)	1998-11-18	2001-02-06	California Institute Of Technology	Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells
US6328765B1 (en)	1998-12-03	2001-12-11	Gore Enterprise Holdings, Inc.	Methods and articles for regenerating living tissue
IN191359B (da)	1999-04-20	2003-11-29	Nat Inst Immunology
US6233476B1 (en)	1999-05-18	2001-05-15	Mediguide Ltd.	Medical positioning system
AU4860900A (en)	1999-06-02	2000-12-18	Lifebank Services, L.L.C.	Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
US8075881B2 (en)	1999-08-05	2011-12-13	Regents Of The University Of Minnesota	Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
US7015037B1 (en)	1999-08-05	2006-03-21	Regents Of The University Of Minnesota	Multiponent adult stem cells and methods for isolation
US8147824B2 (en)	1999-08-05	2012-04-03	Athersys, Inc.	Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US6239157B1 (en)	1999-09-10	2001-05-29	Osiris Therapeutics, Inc.	Inhibition of osteoclastogenesis
WO2001021767A2 (en) *	1999-09-24	2001-03-29	Morphogen Pharmaceuticals, Inc.	Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
US6685936B2 (en)	1999-10-12	2004-02-03	Osiris Therapeutics, Inc.	Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US6280718B1 (en)	1999-11-08	2001-08-28	Wisconsin Alumni Reasearch Foundation	Hematopoietic differentiation of human pluripotent embryonic stem cells
WO2001093909A2 (en)	2000-06-06	2001-12-13	Glaxo Group Limited	Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
KR100947577B1 (ko) *	2000-06-26	2010-03-15	엔씨 메디컬 리서치 가부시키가이샤	신경계 세포로 분화할 수 있는 세포를 포함하는 세포분획
US7311905B2 (en)	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
KR100915483B1 (ko)	2000-12-06	2009-09-03	로버트 제이 하리리	태반 줄기 세포의 회수 방법
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
ES2545899T3 (es) *	2001-02-14	2015-09-16	Anthrogenesis Corporation	Placenta post-parto de mamíferos, su uso y células madre placentarias de la misma
JP2004528021A (ja)	2001-02-14	2004-09-16	アンスロジェネシスコーポレーション	分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
IL157332A0 (en)	2001-02-14	2004-02-19		Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
US20020132343A1 (en) *	2001-03-19	2002-09-19	Clark Lum	System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation
US20030044977A1 (en)	2001-08-10	2003-03-06	Norio Sakuragawa	Human stem cells originated from human amniotic mesenchymal cell layer
US9969980B2 (en)	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
CA2468171C (en)	2001-11-15	2015-10-06	Children's Medical Center Corporation	Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
US7799324B2 (en)	2001-12-07	2010-09-21	Geron Corporation	Using undifferentiated embryonic stem cells to control the immune system
JP3934539B2 (ja)	2001-12-12	2007-06-20	独立行政法人科学技術振興機構	胎盤等由来の成体又は生後組織の前駆細胞
IL162648A0 (en) *	2001-12-21	2005-11-20	Mount Sinai Hospital Corp	Cellular compositions and methods of making and using them
US7682803B2 (en)	2005-10-13	2010-03-23	Anthrogenesis Corporation	Immunomodulation using placental stem cells
MXPA04007732A (es)	2002-02-13	2004-10-15	Anthrogenesis Corp	Celulas madre similares a las embrionarias, derivadas de la placenta de mamiferos despues del parto y usos y metodos de tratamiento usando dichas celulas.
US7736892B2 (en)	2002-02-25	2010-06-15	Kansas State University Research Foundation	Cultures, products and methods using umbilical cord matrix cells
WO2003077865A2 (en)	2002-03-15	2003-09-25	Baxter International Inc.	Methods and compositions for directing cells to target organs
US20030187515A1 (en)	2002-03-26	2003-10-02	Hariri Robert J.	Collagen biofabric and methods of preparing and using the collagen biofabric
US7498171B2 (en)	2002-04-12	2009-03-03	Anthrogenesis Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
CA2481387A1 (en)	2002-04-12	2003-10-23	Celgene Corporation	Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
AU2003262187A1 (en)	2002-04-12	2003-10-27	Celgene Corporation	Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US20030235563A1 (en)	2002-04-19	2003-12-25	Strom Stephen C.	Placental derived stem cells and uses thereof
US20040161419A1 (en)	2002-04-19	2004-08-19	Strom Stephen C.	Placental stem cells and uses thereof
JP2005528105A (ja)	2002-05-30	2005-09-22	セルジーン・コーポレーション	細胞分化をモジュレートするため、並びに骨髄増殖性疾患及び骨髄異形成症候群を治療するためのｊｎｋ又はｍｋｋ阻害剤の使用方法
US7422736B2 (en)	2002-07-26	2008-09-09	Food Industry Research And Development Institute	Somatic pluripotent cells
ES2560847T3 (es)	2002-07-31	2016-02-23	Yves Saint-Laurent Parfums	Células madre procedentes de tejido adiposo y células diferenciadas procedentes de estas células
US20040171147A1 (en)	2002-11-26	2004-09-02	Hariri Robert J.	Cytotherapeutics, cytotherapeutic units and methods for treatments using them
BRPI0407221A (pt)	2003-02-11	2006-01-31	John E Davies	Extrato de geléia de wharton, método para a obtenção de uma célula progenitora humana, métodos para a produção de uma população de células, populações de células e método para a produção de tecido ósseo
AU2004212009B2 (en)	2003-02-13	2010-07-29	Celularity Inc.	Use of umbilical cord blood to treat individuals having a disease, disorder or condition
CN1548529A (zh)	2003-05-09	2004-11-24	中国人民解放军军事医学科学院基础医	一种人胎盘间充质干细胞的分离方法
US7875272B2 (en)	2003-06-27	2011-01-25	Ethicon, Incorporated	Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
EP1641915B1 (en)	2003-06-27	2016-07-27	DePuy Synthes Products, Inc.	Repair and regeneration of ocular tissue using postpartum-derived cells
US20050042595A1 (en)	2003-08-14	2005-02-24	Martin Haas	Banking of multipotent amniotic fetal stem cells
US20050089513A1 (en)	2003-10-28	2005-04-28	Norio Sakuragawa	Side population cells originated from human amnion and their uses
US20050186182A1 (en)	2003-11-10	2005-08-25	Theresa Deisher	Methods of using G-CSF mobilized C-Kit+ cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy
JP2005151907A (ja)	2003-11-27	2005-06-16	Shigeo Saito	胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法
KR20120039065A (ko)	2003-12-02	2012-04-24	셀진 코포레이션	혈색소병증　및　빈혈의　치료　및　관리를　위한　방법및　조성물
US20050176139A1 (en)	2004-01-12	2005-08-11	Yao-Chang Chen	Placental stem cell and methods thereof
US20050266391A1 (en)	2004-01-15	2005-12-01	Bennett Brydon L	Methods for preserving tissue
EP2824175B2 (en)	2004-03-22	2020-10-28	Mesoblast International Sàrl	Mesenchymal stem cells and uses therefor
JP2007531116A (ja)	2004-03-26	2007-11-01	セルジーン・コーポレーション	幹細胞バンクを提供するためのシステム及び方法
WO2005105992A1 (en)	2004-04-21	2005-11-10	New York Eye & Ear Infirmary	Chondrocyte culture formulations
US7244759B2 (en)	2004-07-28	2007-07-17	Celgene Corporation	Isoindoline compounds and methods of making and using the same
US20080292597A1 (en)	2004-07-29	2008-11-27	David A Steenblock	Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases
JP5668208B2 (ja)	2004-08-16	2015-02-12	セルリサーチコーポレイションピーティイーリミテッド	臍帯羊膜からの幹／前駆細胞の単離
US7909806B2 (en)	2004-09-23	2011-03-22	Anthrogenesis Corporation	Cord blood and placenta collection kit
US7147626B2 (en)	2004-09-23	2006-12-12	Celgene Corporation	Cord blood and placenta collection kit
WO2006083394A2 (en)	2004-12-21	2006-08-10	Ethicon, Inc.	Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
WO2006101548A2 (en)	2004-12-21	2006-09-28	Ethicon, Inc.	Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
EP1833496B1 (en)	2004-12-23	2013-07-31	Ethicon, Incorporated	Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
US20070041943A1 (en)	2004-12-29	2007-02-22	Children's Hospital Research	Expression of virus entry inhibitors and recombinant AAV thereof
US7642091B2 (en)	2005-02-24	2010-01-05	Jau-Nan Lee	Human trophoblast stem cells and use thereof
US20060222634A1 (en)	2005-03-31	2006-10-05	Clarke Diana L	Amnion-derived cell compositions, methods of making and uses thereof
KR20080031735A (ko) *	2005-06-10	2008-04-10	셀진 코포레이션	인간 태반 콜라겐 조성물, 그의 제조 방법, 그의 사용 방법및 상기 조성물을 포함하는 키트
AU2006265601A1 (en) *	2005-06-30	2007-01-11	Anthrogenesis Corporation	Repair of tympanic membrane using placenta derived collagen biofabric
US20070021762A1 (en) *	2005-07-13	2007-01-25	Qing Liu	Ocular plug formed from placenta derived collagen biofabric
EP1919500A2 (en)	2005-07-13	2008-05-14	Anthrogenesis Corporation	Treatment of leg ulcers using placenta derived collagen biofabric
WO2007011693A2 (en) *	2005-07-14	2007-01-25	Medistem Laboratories, Inc.	Compositions of placentally-derived stem cells for the treatment of cancer
WO2007047465A1 (en)	2005-10-13	2007-04-26	Anthrogenesis Corporation	Production of oligodendrocytes from placenta-derived stem cells
AU2006332679A1 (en)	2005-12-29	2007-07-12	Anthrogenesis Corporation	Co-culture of placental stem cells and stem cells from a second source
PT2471905T (pt)	2005-12-29	2019-01-11	Celularity Inc	Populações de células estaminais placentárias
JP2009521931A (ja)	2005-12-29	2009-06-11	アントフロゲネシスコーポレーション	胎盤幹細胞を収集及び保存するための改善された組成物、及び該組成物の使用方法
ZA200810412B (en) *	2006-06-09	2010-03-31	Anthrogenesis Corp	Placental niche and use thereof to culture stem cells
US20090251642A1 (en)	2006-07-18	2009-10-08	Runa Nakamura	Retardation film, brightness enhancement film, polarizing plate, producing method of a retardation film, and liquid crystal display
US7993918B2 (en)	2006-08-04	2011-08-09	Anthrogenesis Corporation	Tumor suppression using placental stem cells
US8105634B2 (en) *	2006-08-15	2012-01-31	Anthrogenesis Corporation	Umbilical cord biomaterial for medical use
US8122763B2 (en)	2006-09-01	2012-02-28	Avair, Llc	Breathing gas supply visual broadcast apparatus
US20080131522A1 (en) *	2006-10-03	2008-06-05	Qing Liu	Use of placental biomaterial for ocular surgery
US8071135B2 (en) *	2006-10-04	2011-12-06	Anthrogenesis Corporation	Placental tissue compositions
CA2665369C (en) *	2006-10-06	2023-01-10	Anthrogenesis Corporation	Human placental collagen compositions, and methods of making and using the same
CN101631852A (zh)	2006-10-23	2010-01-20	人类起源公司	用胎盘细胞群治疗骨缺损的方法和组合物
RS52921B (sr)	2007-02-12	2014-02-28	Anthrogenesis Corporation	Lečenje inflamatornih bolesti upotrebom placentnih matičnih ćelija
US10494607B2 (en) *	2007-02-12	2019-12-03	Celularity, Inc.	CD34+,CD45−placental stem cell-enriched cell populations
US20100172830A1 (en)	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
MX2010003217A (es) *	2007-09-26	2010-07-30	Celgene Cellular Therapeutics	Celulas angiogenicas de perfundido de placenta humana.
CA2700617C (en)	2007-09-28	2018-11-06	Celgene Cellular Therapeutics	Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
DK2217329T3 (da) *	2007-11-07	2018-04-23	Anthrogenesis Corp	Anvendelse af navlestrengsblod i behandlingen af komplikationer i forbindelse med præterm fødsel
CN105766891A (zh)	2008-08-20	2016-07-20	人类起源公司	改进的细胞组合物及制备所述组合物的方法
CN105796602A (zh)	2008-08-20	2016-07-27	人类起源公司	利用分离的胎盘细胞治疗中风
CA2965883C (en)	2008-08-22	2020-05-12	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
ES2749500T3 (es)	2008-11-19	2020-03-20	Celularity Inc	Células adherentes derivadas del amnios
RU2732240C2 (ru)	2008-11-21	2020-09-14	Антродженезис Корпорейшн	Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток
WO2010141654A1 (en)	2009-06-05	2010-12-09	Anthrogenesis Corporation	Improved method of collecting placental cells
EP2449095A1 (en)	2009-07-02	2012-05-09	Anthrogenesis Corporation	Method of producing erythrocytes without feeder cells
US9121007B2 (en)	2010-01-26	2015-09-01	Anthrogenesis Corporatin	Treatment of bone-related cancers using placental stem cells
US20110280849A1 (en)	2010-03-26	2011-11-17	Anthrogenesis Corporation	Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds
EP2556145B1 (en)	2010-04-07	2016-07-20	Anthrogenesis Corporation	Angiogenesis using placental stem cells
MX2012011543A (es)	2010-04-08	2013-05-06	Anthrogenesis Corp	Tratamiento de sarcoidosis empleando celulas madre placentarias.
JP5996533B2 (ja)	2010-07-13	2016-09-21	アントフロゲネシスコーポレーション	ナチュラルキラー細胞を生成させる方法
JP2014514245A (ja)	2010-12-30	2014-06-19	アントフロゲネシスコーポレーション	細胞を凍結保存及びカプセル封入する方法
WO2012092458A2 (en)	2010-12-30	2012-07-05	Anthrogenesis Corporation	Compositions comprising placental stem cells and platelet rich plasma, and methods of use thereof
WO2012092485A1 (en)	2010-12-31	2012-07-05	Anthrogenesis Corporation	Enhancement of placental stem cell potency using modulatory rna molecules

2001
- 2001-12-05 KR KR1020087015591A patent/KR100915483B1/ko not_active Expired - Lifetime
- 2001-12-05 EP EP01999637.0A patent/EP1349918B1/en not_active Expired - Lifetime
- 2001-12-05 JP JP2002548091A patent/JP4294316B2/ja not_active Expired - Lifetime
- 2001-12-05 CA CA002678490A patent/CA2678490A1/en not_active Abandoned
- 2001-12-05 EP EP10153834A patent/EP2206772A3/en not_active Withdrawn
- 2001-12-05 AU AU2020902A patent/AU2020902A/xx active Pending
- 2001-12-05 EP EP10183378.8A patent/EP2305795B1/en not_active Expired - Lifetime
- 2001-12-05 MX MXPA03005014A patent/MXPA03005014A/es active IP Right Grant
- 2001-12-05 AU AU2002220209A patent/AU2002220209B2/en not_active Expired
- 2001-12-05 KR KR1020037007561A patent/KR100915482B1/ko not_active Expired - Lifetime
- 2001-12-05 EP EP17185781.6A patent/EP3299452A1/en not_active Withdrawn
- 2001-12-05 IL IL15630301A patent/IL156303A0/xx unknown
- 2001-12-05 CA CA002430989A patent/CA2430989A1/en not_active Abandoned
- 2001-12-05 WO PCT/US2001/046506 patent/WO2002046373A1/en not_active Ceased
- 2001-12-05 EP EP10183435A patent/EP2322601A1/en not_active Withdrawn
- 2001-12-05 ES ES01999637.0T patent/ES2522890T3/es not_active Expired - Lifetime
- 2001-12-05 US US10/004,942 patent/US7045148B2/en not_active Expired - Lifetime
- 2001-12-05 DK DK01999637.0T patent/DK1349918T3/da active
2003
- 2003-06-03 ZA ZA200304341A patent/ZA200304341B/en unknown
- 2003-06-04 IL IL156303A patent/IL156303A/en active IP Right Grant
2005
- 2005-07-21 US US11/187,400 patent/US7638141B2/en not_active Expired - Lifetime
2008
- 2008-10-27 US US12/259,259 patent/US8580563B2/en not_active Expired - Fee Related
- 2008-12-22 US US12/341,961 patent/US7976836B2/en not_active Expired - Lifetime
2009
- 2009-11-13 US US12/618,664 patent/US8986984B2/en not_active Expired - Fee Related
2010
- 2010-10-06 IL IL208510A patent/IL208510A/en active IP Right Grant
2011
- 2011-05-16 US US13/108,891 patent/US20110223141A1/en not_active Abandoned
- 2011-05-16 US US13/108,871 patent/US9149569B2/en not_active Expired - Lifetime
- 2011-05-16 US US13/108,901 patent/US8545833B2/en not_active Expired - Fee Related
- 2011-05-24 IL IL213109A patent/IL213109A/en active IP Right Grant
- 2011-09-30 US US13/251,059 patent/US8293223B2/en not_active Expired - Fee Related
- 2011-10-03 US US13/252,142 patent/US20120020936A1/en not_active Abandoned
2014
- 2014-06-06 US US14/298,294 patent/US9387283B2/en not_active Expired - Fee Related
2015
- 2015-02-06 US US14/616,167 patent/US20150175959A1/en not_active Abandoned
2016
- 2016-06-09 US US15/177,779 patent/US10113146B2/en not_active Expired - Lifetime
2018
- 2018-09-26 HK HK18112337.7A patent/HK1252977A1/en unknown

Also Published As

Publication number	Publication date
EP2305795A1 (en)	2011-04-06
AU2020902A (en)	2002-06-18
EP2322601A1 (en)	2011-05-18
MXPA03005014A (es)	2004-09-10
WO2002046373A9 (en)	2003-01-09
US20110217272A1 (en)	2011-09-08
US9149569B2 (en)	2015-10-06
EP2206772A2 (en)	2010-07-14
US20150175959A1 (en)	2015-06-25
US8580563B2 (en)	2013-11-12
US7638141B2 (en)	2009-12-29
WO2002046373A8 (en)	2002-10-10
US20100120015A1 (en)	2010-05-13
KR100915483B1 (ko)	2009-09-03
IL208510A (en)	2015-11-30
US20160289634A1 (en)	2016-10-06
KR20080064915A (ko)	2008-07-09
JP4294316B2 (ja)	2009-07-08
WO2002046373A1 (en)	2002-06-13
EP2305795B1 (en)	2019-07-03
HK1252977A1 (en)	2019-06-06
US20020123141A1 (en)	2002-09-05
EP1349918B1 (en)	2014-08-06
CA2678490A1 (en)	2002-06-13
DK1349918T3 (da)	2014-11-10
KR20030081345A (ko)	2003-10-17
US20050272148A1 (en)	2005-12-08
ZA200304341B (en)	2004-09-14
AU2002220209B2 (en)	2006-05-25
IL213109A (en)	2015-09-24
US7045148B2 (en)	2006-05-16
EP1349918A1 (en)	2003-10-08
US20110217271A1 (en)	2011-09-08
US8986984B2 (en)	2015-03-24
IL208510A0 (en)	2010-12-30
US20120020936A1 (en)	2012-01-26
CA2430989A1 (en)	2002-06-13
IL156303A (en)	2011-07-31
US7976836B2 (en)	2011-07-12
KR100915482B1 (ko)	2009-09-03
US20140349391A1 (en)	2014-11-27
US8545833B2 (en)	2013-10-01
US9387283B2 (en)	2016-07-12
US20110223141A1 (en)	2011-09-15
US8293223B2 (en)	2012-10-23
ES2522890T3 (es)	2014-11-19
JP2004523220A (ja)	2004-08-05
US10113146B2 (en)	2018-10-30
US20090053805A1 (en)	2009-02-26
EP3299452A1 (en)	2018-03-28
EP2206772A3 (en)	2010-08-04
EP1349918A4 (en)	2004-07-21
US20120058089A1 (en)	2012-03-08
IL213109A0 (en)	2011-07-31
US20090142831A1 (en)	2009-06-04

Publication	Publication Date	Title
IL208510A0 (en)	2010-12-30	Method of collecting placental stem cells
IL207024A0 (en)	2010-12-30	Post-partum mammaliand placental stem cells
IL162663A0 (en)	2005-11-20	A method for the establishment of apluripotent human blastocyst-derived stem cell line
IL156234A0 (en)	2004-01-04	Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
HUP0301575A3 (en)	2010-01-28	Methods of modifying eukaryotic cells
AU2001257300A1 (en)	2001-11-07	Method for the transformation of plant cell plastids
IL149802A0 (en)	2002-11-10	Method of cryopreserving selected sperm cells
IL162131A (en)	2010-12-30	Methods for obtaining islet cells from human embryonic stem cells
EP1325953A4 (en)	2006-03-22	METHOD FOR CULTIVATING MESENCHYMAL STEM CELLS
GB0113118D0 (en)	2001-07-18	Stem Cells
AU2002230669A1 (en)	2002-05-15	Postmortem stem cells
AU7771801A (en)	2002-02-25	Method for manufacturing solar cell and solar cell
IL139322A0 (en)	2001-11-25	Process for obtaining stem cells
GB0026252D0 (en)	2000-12-13	Pluripotential stem cells
EP1445311A4 (en)	2005-01-12	METHOD FOR AMPLIFYING STEM HEMATOPOIETIC CELLS
GB0416516D0 (en)	2004-08-25	Method of transducing es cells
GB0025088D0 (en)	2000-11-29	Stem cells
HK1060367A (en)	2004-08-06	Method of collecting placental stem cells
GB0013817D0 (en)	2000-07-26	Method for treating cells
EP1337546A4 (en)	2004-09-22	METHOD FOR DETECTING HEMATOPOETIC STEM CELLS
GB0024938D0 (en)	2000-11-29	Method of diagnosis
PL338405A1 (en)	2000-08-14	Method of obtaining 2-quinoxalincarboxylic acid
GB0012615D0 (en)	2000-07-12	Method for selection of genetically transformed cells
GB0011670D0 (en)	2000-07-05	Method for selection of genetically transformed cells
TW500028U (en)	2002-08-21	Improved structure for stem portion of hand tool